Compare Novavax Inc (NVAX) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novavax Inc vs Payoneer Global Inc — how do they compare? Novavax Inc trades at $7.96 (market cap $1.31B), while Payoneer Global Inc trades at $7.08 (market cap $2.40B). The key difference: Payoneer Global Inc is the larger of the two by market cap, and Payoneer Global Inc is trading nearer its 52-week high, Novavax Inc nearer its low. Which is the better fit depends on your goals.
| NVAX | PAYO | |
|---|---|---|
Market Cap | $1.31B | $2.40B |
Sector | Health | Technology |
52-Week High | $11.19 | $7.17 |
52-Week Low | $6.22 | $4.27 |
Enterprise Value | $889.30M | $2.14B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Novavax Inc
Novavax, Inc. is a clinical stage biotechnology company. The Company creates novel vaccines to address a broad range of infectious diseases worldwide using proprietary virus-like particle (VLP) technology.
Read more on NVAX →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
